Diabetes, Vol 46, Issue 8 1270-1275, Copyright © 1997 by American Diabetes Association

ARTICLES

Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes

M Hawa, R Rowe, MS Lan, AL Notkins, P Pozzilli, MR Christie and RD Leslie
Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, U.K.

Islet antigens associated with type 1 diabetes include a recently identified protein tyrosine phosphatase-like molecule IA-2, which contains the intracellular fragment IA-2ic. To determine whether combinations of antibodies including those to IA-2 characterize and predict type 1 diabetes, we studied antibodies to IA-2, IA-2ic, glutamic acid decarboxylase (GAD65), and islet cell antibodies (ICAs) in 1) 60 newly diagnosed type 1 diabetic patients followed for 1 year, 2) 31 monozygotic twin pairs discordant for type 1 diabetes followed up to 12 years (11 twins developed diabetes), 3) 18 dizygotic twin pairs discordant for type 1 diabetes, and 4) normal healthy control subjects. Newly diagnosed type 1 diabetic patients frequently had antibodies to IA-2 (62%), IA-2ic (67%), GAD65 (77%), and ICAs (85%). The intracellular fragment of IA-2 probably contains the immunodominant epitope as 137 of 143 samples with IA-2 antibodies from type 1 diabetic patients also had IA-2ic antibodies. Monozygotic twins were usually discordant for antibody specificities. Concordance was higher in monozygotic than matched dizygotic twins for both antibody combinations (33 vs. 6%, P < 0.05) and the development of diabetes (33 vs. 0%, P < 0.01). In monozygotic twins, all the antibodies were highly predictive of type 1 diabetes (positive predictive values all >87%), although antibodies were also detected in twins at low risk of disease. In summary, IA-2 emerges as a major antigen associated with type 1 diabetes and distinct from GAD65. Type 1 diabetes-associated autoimmunity, which is probably induced by environmental factors, does not necessarily herald progression to the disease. However, genetic factors may influence the development of combinations of disease-associated antibodies and the progression to type 1 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 Diabetes, May 1, 2008; 57(5): 1276 - 1283. [Abstract] [Full Text] [PDF]

				H. Beyan, M. R. Goodier, N. S. Nawroly, M. I. Hawa, S. A. Bustin, W. B. Ogunkolade, M. Londei, N. Yousaf, and R. D. G. Leslie Altered Monocyte Cyclooxygenase Response to Lipopolysaccharide in Type 1 Diabetes Diabetes, December 1, 2006; 55(12): 3439 - 3445. [Abstract] [Full Text] [PDF]

				S.-i. Harashima, A. Clark, M. R. Christie, and A. L. Notkins The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion PNAS, June 14, 2005; 102(24): 8704 - 8709. [Abstract] [Full Text] [PDF]

				M. I. Hawa, R. Bonfanti, C. Valeri, M. Delli Castelli, H. Beyan, and R. D. G. Leslie No Evidence for Genetically Determined Alteration in Insulin Secretion or Sensitivity Predisposing to Type 1 Diabetes: A study of identical twins Diabetes Care, June 1, 2005; 28(6): 1415 - 1418. [Abstract] [Full Text] [PDF]

				W. E. Winter, N. Harris, and D. Schatz Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes Clin. Diabetes, October 1, 2002; 20(4): 183 - 191. [Abstract] [Full Text] [PDF]

				K. Saeki, M. Zhu, A. Kubosaki, J. Xie, M. S. Lan, and A. L. Notkins Targeted Disruption of the Protein Tyrosine Phosphatase-Like Molecule IA-2 Results in Alterations in Glucose Tolerance Tests and Insulin Secretion Diabetes, June 1, 2002; 51(6): 1842 - 1850. [Abstract] [Full Text] [PDF]

				H. Snieder, P. A. Sawtell, L. Ross, J. Walker, T. D. Spector, and R. D. G. Leslie HbA1c Levels Are Genetically Determined Even in Type 1 Diabetes: Evidence From Healthy and Diabetic Twins Diabetes, December 1, 2001; 50(12): 2858 - 2863. [Abstract] [Full Text] [PDF]

				M. Gylling, T. Tuomi, P. Björses, S. Kontiainen, J. Partanen, M. R. Christie, M. Knip, J. Perheentupa, and A. Miettinen {beta}-Cell Autoantibodies, Human Leukocyte Antigen II Alleles, and Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4434 - 4440. [Abstract] [Full Text]

				A. E. Herman, R. M. Tisch, S. D. Patel, S. L. Parry, J. Olson, J. A. Noble, A. P. Cope, B. Cox, M. Congia, and H. O. McDevitt2 Determination of Glutamic Acid Decarboxylase 65 Peptides Presented by the Type I Diabetes-Associated HLA-DQ8 Class II Molecule Identifies an Immunogenic Peptide Motif J. Immunol., December 1, 1999; 163(11): 6275 - 6282. [Abstract] [Full Text] [PDF]

				M. J Redondo, M. Rewers, L. Yu, S. Garg, C. C Pilcher, R. B Elliott, and G. S Eisenbarth Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study BMJ, March 13, 1999; 318(7185): 698 - 702. [Abstract] [Full Text]